Bausch + Lomb (BLCO) vs Cooper Companies (COO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Bausch + Lomb (BLCO) has outperformed Cooper Companies (COO) over the past year, gaining 16.6% versus a loss of 20.7%. Cooper Companies is the larger company by market cap ($10.33 billion vs $6.13 billion), about 1.7 times the size, while Bausch + Lomb is growing revenue faster (+6.5% vs +5.1%). On valuation, Cooper Companies trades at a lower forward P/E (11.6x vs 15.4x for Bausch + Lomb).
Cooper Companies converts more of its revenue into profit, with a net margin of 9.2% versus -7.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BLCO | COO |
|---|---|---|
| Share price | $17.15 | $54.30 |
| Market cap | $6.13B | $10.33B |
| 1-day change | -1.10% | -0.82% |
| YTD return | +0.41% | -33.20% |
| 1-year return | +16.59% | -20.68% |
| 5-year return | — | -45.02% |
| P/E ratio (TTM) | — | 18.66 |
| Forward P/E | 15.40 | 11.57 |
| EPS (TTM) | $-0.49 | $2.91 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $5.10B | $4.09B |
| Revenue growth (YoY) | +6.47% | +5.06% |
| Net income (latest FY) | $-360.00M | $374.90M |
| Gross margin | — | 65.54% |
| Operating margin | 2.22% | 16.69% |
| Net margin | -7.06% | 9.16% |
| 52-week high | $18.92 | $89.83 |
| 52-week low | $13.77 | $51.01 |
| Distance from 52-week high | -9.33% | -39.55% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +13.06% | +21.18% |
| Average volume | 392.13K | 3.13M |
| Shares outstanding | 357.17M | 190.16M |
| Employees | 13,000 | 15,000 |
| Sector | Health Care | Health Care |
| Industry | Ophthalmic Goods | Ophthalmic Goods |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BLCO has outperformed COO by 37.3 percentage points over the past year.
- Cooper Companies is more profitable, keeping 9.2 cents of every revenue dollar as net income versus -7.1 cents for Bausch + Lomb.
About Bausch + Lomb
BLCO stock →Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical.
Health Care · Ophthalmic Goods · 13,000 employees
About Cooper Companies
COO stock →The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical.
Health Care · Ophthalmic Goods · 15,000 employees
BLCO vs COO FAQ
Which is bigger, Bausch + Lomb or Cooper Companies?
Cooper Companies (COO) is larger, with a market capitalization of $10.33B compared with $6.13B for Bausch + Lomb (BLCO).
Which stock has performed better over the past year, BLCO or COO?
BLCO returned +16.59% over the past 12 months, compared with -20.68% for COO (price return, excluding dividends). Past performance does not predict future results.
Are Bausch + Lomb and Cooper Companies in the same industry?
Yes. Both are classified in the Ophthalmic Goods industry within the Health Care sector.